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Metabolic syndrome in young children: deﬁnitions and
results of the IDEFICS study
W Ahrens1,2,13, LA Moreno3,13, S Mårild4, D Molnár5, A Siani6, S De Henauw7, J Böhmann8, K Günther1, C Hadjigeorgiou9,
L Iacoviello10, L Lissner11, T Veidebaum12, H Pohlabeln1,14 and I Pigeot1,2,14 on behalf of the IDEFICS consortium
OBJECTIVE: To estimate the prevalence of the metabolic syndrome (MetS) using reference standards obtained in European
children and to develop a quantitative MetS score and describe its distribution in children.
DESIGN AND METHODS: Population-based survey in eight European countries, including 18 745 children 2.0 to 10.9 years,
recruited during a second survey. Anthropometry (weight, height and waist circumference), blood pressure and serum-fasting
triglycerides, HDL cholesterol, glucose and insulin were measured. We applied three widely accepted deﬁnitions of the pediatric
MetS and we suggest a new deﬁnition, to guide pediatricians in decisions about close monitoring or even intervention (values of at
least three of the MetS components exceeding the 90th or 95th percentile, respectively). We used a z-score standardisation to
calculate a continuous score combining the MetS components.
RESULTS: Among the various deﬁnitions of MetS, the highest prevalence (5.5%) was obtained with our new deﬁnition requiring
close observation (monitoring level). Our more conservative deﬁnition, requiring pediatric intervention gives a prevalence of 1.8%.
In general, prevalences were higher in girls than in boys. The prevalence of metabolic syndrome is highest among obese children.
All deﬁnitions classify a small percentage of thin or normal weight children as being affected. The metabolic syndrome score shows
a positive trend with age, particularly regarding the upper percentiles of the score.
CONCLUSIONS: According to different deﬁnitions of pediatric MetS, a non-negligible proportion of mostly prepubertal children
are classiﬁed as affected. We propose a new deﬁnition of MetS that should improve clinical guidance. The continuous
score developed may also serve as a useful tool in pediatric obesity research. It has to be noted, however, that the proposed cutoffs
are based on a statistical deﬁnition that does not yet allow to quantify the risk of subsequent disease.
International Journal of Obesity (2014) 38, S4–S14; doi:10.1038/ijo.2014.130
INTRODUCTION
Cardiovascular diseases are one of the most common causes of
mortality in developed countries.1 Several risk factors have
been identiﬁed as major determinants of these diseases, like
hypertension, dyslipidaemia, type 2 diabetes and smoking.2,3 Some
of them, or their precursors, can already be identiﬁed in youth.4
Cardiovascular risk factors tend to cluster, not only in adults, but
also in children.5,6 Factor analyses in children have shown that
single risk factors can be grouped into 2 to 4 aggregate factors.7,8
The metabolic syndrome in adults is generally deﬁned
as a cluster of cardiovascular risk factors, namely central
obesity, hyperglycaemia, dyslipidaemia and elevated blood
pressure, which are often associated with a condition of insulin
resistance.9,10
The metabolic syndrome has been already described in young
populations.11 Several authors have reported the prevalence
of the metabolic syndrome in children.12 However, there is no
consensus about the deﬁnition of the metabolic syndrome in
children.13 This is mainly due to the fact that there are no
reference values for the different components to be used during
childhood.14 From this point of view, reference values provided
by the IDEFICS (Identiﬁcation and prevention of Dietary- and
lifestyle-induced health Effects in Children and infantS) study15 of
European children may allow us to classify children according
to the different components of the syndrome (see Nagy et al.,16
Barba et al.,17 De Henauw et al.,18 Peplies et al.;19 this issue).
At the population level, another approach to address the
clustering of cardiovascular risk factors is to compute a
quantitative risk score.20 Pandit et al.21 found that a continuous
metabolic syndrome score was a better tool to assess athero-
sclerotic risk in children than individual metabolic syndrome
components, where that risk was assessed in terms of carotid
intima-media thickness and vascular stiffness parameters as
subclinical endpoints. Such risk scores were already used in
different studies, mainly trying to identify their association with
lifestyle risk factors, that is, dietary intake and physical activity.22–24
The aim of our study is to estimate the prevalence of the
metabolic syndrome using reference standards obtained in
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healthy European children from the IDEFICS study. Based on the
distribution of components of the metabolic syndrome in the
IDEFICS cohort, we propose a new deﬁnition of the metabolic
syndrome to guide pediatricians’ decisions to conduct either
close monitoring (monitoring level) or even an intervention
(action level) in affected children. We also compare our results
with those obtained using existing deﬁnitions of the metabolic
syndrome in children. Finally, we develop a quantitative
cardiovascular risk score and describe its distribution in our
cohort of mostly prepubertal children.
SUBJECTS AND METHODS
Study subjects
A cohort of 16 228 children aged 2–9 years was examined in a population-
based baseline survey in eight European countries ranging from North to
South and from East to West (Sweden, Germany, Hungary, Italy, Cyprus,
Spain, Belgium, Estonia) from autumn 2007 to spring 2008. While we
recruited study subjects from typical regional population clusters in each
country, the study was not designed to provide a nationally representative
sample. Rather, this baseline survey (T0) was the starting point of the
prospective study with the largest European children’s cohort established
to date.15 Together with an additional 2517 children aged 2.0–10.9 years
who were newly recruited during a second survey (T1) 2 years later, this
cohort formed the basis for the present analysis. Exactly the same survey
modules were deployed at baseline (T0) and at follow-up (T1).
All children in the deﬁned age group who resided in the study regions
and who attended the selected primary schools (grades 1 and 2), pre-
schools or kindergartens were eligible for participation. Children were
approached via schools and kindergartens to facilitate equal enrolment of
all social groups. In addition to the signed informed consent given by
parents, each child was asked to give verbal assent immediately before
examination.
Although all participants were asked to attend the study centre in the
morning after an overnight fast for the blood draw and those examinations
requiring a fasting status (for example, measurement of waist circumfer-
ence), all children were asked whether they had eaten anything just before
the examination. Those children who reported to be nonfasting were
excluded from the analysis group. Thus our ﬁnal analysis group consisted
of at most 18 169 children: the subsequent analyses are based on varying
sample sizes depending on the measurement of interest as it was possible
for children to opt out for certain modules of the examination.
Questionnaires and examinations
Parents ﬁlled in a self-completion questionnaire to assess gestational,
behavioural and sociodemographic factors and a children’s eating habits
questionnaire on frequency of food consumption and dietary habits.
The examination programme included standard anthropometric
measures,25 such as weight, height, skinfolds and waist circumference,
clinical parameters such as blood pressure, collection of urine, saliva
and blood for further medical parameters and genetic analyses, and
accelerometry to assess physical activity. In this section, we describe the
measurements that were considered in our analysis.
Anthropometry. Weight was measured with an electronic scale (Tanita BC
420 SMA, Tanita Europe GmbH, Sindelﬁngen, Germany) to the nearest
0.1 kg. The children wore only underwear and a T-shirt. Height
was measured, barefoot, using a telescopic height measuring instrument
(Seca 225 stadiometer, seca, Birmingham, UK) to the nearest 0.1 cm. Body
mass index was calculated as weight in kilograms divided by the square of
the height in metres. Children were classiﬁed as normal weight,
overweight or obese according to the cutoffs by the International
Childhood Obesity Task Force, recently updated by Cole and Lobstein.26
Circumference measurements were taken at four sites: arm, waist, hip and
neck with an inelastic tape (Seca 200). The measurement of waist
circumference was obtained in upright position with relaxed abdomen and
feet together, midway between the lowest rib margin and the iliac crest to
the nearest 0.1 cm (see Nagy et al.;16 this issue).
Blood pressure. Blood pressure was measured with an automated
oscillometric device (Welch Allyn 4200B-E2, Welch Allyn Inc., New York,
NY, USA),27 according to a standardised procedure as described in
Barba et al.17 (this issue). The cuff length for blood pressure measurement
was chosen according to the arm circumference value.28 Children were
asked to sit for at least 5 min before measurement. Two records were
taken, with 2-min interval in between, plus a further one in case
of difference > 5% in blood pressure between the two previous readings.
The average of the two (or three) measurements was used for statistical
analysis.
Blood collection. We aimed to obtain fasting blood from all children via
either venipuncture or capillary sampling. To ensure that basic data on
metabolic disturbances were available for as many children as possible, a
point-of-care analyser was used to assess blood glucose, HDL and LDL
cholesterol and triglycerides in one drop of capillary blood from the
ﬁngertip on the spot. To avoid the ﬁnger prick in children who agreed to
the venipuncture, one drop of venous blood was used for the point-of-care
analysis. Blood was immediately transferred from the capillary tube to
Cholestech LDX (Cholestech Corp.)29 test cassettes by capillary plungers.
The Cholestech LDX measures total cholesterol and HDL cholesterol by the
enzymatic method of Roeschlau and Allain, triglycerides by an enzymatic
method based on the hydrolysis of triglycerides and glucose by an
enzymatic method using glucose oxidase. The Cholestech LDX uses
reﬂectance photometry to measure the analyte concentration. The
analyser automatically calculates LDL cholesterol values. Point-of-care
analysis was then done within 5 min of blood withdrawal. Blood samples
were processed to separate serum/plasma and stored at − 80 °C. All blood,
serum, urine and saliva samples were transferred to a central bio-
repository to coordinate the laboratory analyses and to ensure standar-
dised storage and handling of samples.30 Serum insulin concentrations
were measured by luminescence immunoassay in a central laboratory.
We used an AUTO-GA Immulite 2000, Siemens, Eschborn, Germany. As a
measure of insulin resistance, we used the homeostasis model assessment
(HOMA-IR)31 using fasting glucose and plasma insulin where HOMA-IR
was calculated as fasting insulin (μIU ml− 1) × fasting glucose (mg dl− 1)/405
(see Peplies et al.;19 this issue).
Quality management
All measurements followed detailed standard operation procedures.32
Field personnel from each study centre participated in central training and
organised local training sessions thereafter. Adherence of ﬁeld staff to
the standard operation procedures was checked during on-site visits.
Questionnaires were developed in English, translated to local languages
and then back-translated to check for translation errors. All study centres
used the same technical equipment. Databases and computer-assisted
questionnaires included automated plausibility checks. All numerical
variables were entered twice independently. To further check for the
quality of data, subsamples of study subjects were examined repeatedly to
calculate the inter- and intra-observer reliability of anthropometric
measurements.33
Deﬁnition of metabolic syndrome
We applied three commonly used deﬁnitions34–36 of the pediatric
metabolic syndrome (MetS) to create the analysis groups for our statistical
analyses. The deﬁnition by Cook et al.34 corresponds to the NCEP (National
Cholesterol Education Program) deﬁnition adapted to adolescents. It may
thus not be appropriate for smaller children, but it is the most widely used
deﬁnition in pediatric practice. We did not consider the deﬁnitions
suggested by the WHO (World Health Organisation) and its modiﬁed
version for nondiabetic subjects by EGIR (Group for the Study of Insulin
Resistance) as they are provided for adults only with no adaptation for
children. The IDF (International Diabetes Federation) provided a deﬁnition
of MetS adapted for children which we used.36 The deﬁnition by Viner
et al.35 is based on only 103 obese children from UK and adolescents
of different ethnicities to identify a high-risk group among the obese.
However, it is a widely accepted deﬁnition, which is frequently used by
physicians. In addition, it is the only one including serum-fasting insulin, a
key component of the metabolic syndrome, especially at early stages.
Each of the three deﬁnitions we selected has its limitations but there are
reasons to see them as the best currently on offer. They are summarised in
Table 1 and compared with the new deﬁnitions we propose. Each of them
considers the following four major cardiovascular risk factors used for
deﬁning MetS in adults: (1) excess adiposity, (2) blood pressure, (3) blood
lipids and (4) blood glucose/insulin,13 which are components of the
metabolic syndrome. According to these deﬁnitions, a child is diagnosed
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with MetS if a predeﬁned critical value is exceeded for three or more of
these risk factors. Based on the most recent age-speciﬁc percentiles
derived for these risk factors from the IDEFICS study, we suggest an
updated deﬁnition of the pediatric MetS, which is also given in Table 1. As
we observed an effect of age and sex on all components of MetS, we
considered age- and sex-speciﬁc percentiles for each of them. We have
considered the same components using two different cutoffs, to guide
pediatricians in deciding whether close monitoring is appropriate (values
of at least three of the components of MetS exceeding the 90th percentile)
or even an intervention (values of at least three of the components of MetS
exceeding the 95th percentile) in affected children.
Deﬁnition of the metabolic syndrome score
Following a similar approach as Eisenmann,20 we used a z-score
standardisation to calculate a continuous score that combines the
components used to deﬁne MetS in adults, that is, waist circumference,
blood pressure, dyslipidaemia and hyperglycaemia. The additive score is
deﬁned as the sum of sex- and age-speciﬁc z-scores of waist circumference
and HOMA index. A higher score indicates a less-favourable metabolic
proﬁle. Instead of using the mean arterial pressure we added the mean of
the z-scores of diastolic and systolic blood pressure to this additive MetS
score. Eisenmann included the z-scores of HDL-C and triglycerides as two
separate components of the total score, whereas, we calculated the mean
of the sex- and age-speciﬁc z-scores of HDL-C (multiplied with − 1, due to
the inverse association between HDL-C and the metabolic risk proﬁle) and
triglycerides and added this mean z-score to the total MetS score. In this
way, dyslipidaemia receives the same weight as the other three
components in our deﬁnition of the MetS score. Four examples illustrating
the calculation of the MetS score are given for arbitrarily chosen children in
Appendix A in analogy to Eisenmann.20
Sex- and age-speciﬁc z-scores (that is, standardised residuals) were
calculated based on GAMLSS models of the corresponding variables, that
is, waist circumference (see Nagy et al.;16 this issue) and HOMA (see Peplies
et al.;19 this issue) based on the Box–Cox t distribution and HDL-C (see De
Henauw et al.;18 this issue) based on the Box–Cox-Power-Exponential
distribution. Z-scores of blood pressure were calculated as sex-, age-, and
height-speciﬁc values based on a Box–Cox t distribution (see Barba et al.;17
this issue).
Triglycerides were measured with a detection limit of 0.51mmol l− 1
(45mg dl− 1). Measurements in 55.9% of boys and 46.8% of girls fell below
this detection limit. Thus the distribution of triglycerides was strongly
skewed and available distributions in the gamlss package could not be
ﬁtted accurately. Hence, based on the uniform distribution, triglyceride
values below 0.51mmol l− 1 (45mg dl− 1) were repeatedly randomised to
values between 0.51 and 0.19mmol l− 1 (45–17mg dl− 1), which was the
lowest reported value found for school children.40 These simulated data
were combined with the measured values to create one data set that was
then used to ﬁt a statistical model describing these data best. Sensitivity
analyses showed that the resulting model was quite robust against the
choice of the distribution used for the simulation of values below the
detection limit. The ﬁnal model for boys and girls is based on a Box–Cox
Cole and Green distribution without age effects, that is, μ, log(σ) and
ν were modelled as constant. As a result, sex-speciﬁc but not age-speciﬁc
z-scores were calculated for triglycerides.
Statistical analysis
We applied each of the widely accepted deﬁnitions summarised in Table 1
as well as our own characterisation of pediatric metabolic syndrome to the
IDEFICS data set and calculated sex-speciﬁc prevalences, stratiﬁed by
weight status (thinness/normal weight, overweight, obesity) according to
Cole and Lobstein.26 The degree of agreement between the diagnostic
criteria of Cook et al.,34 Viner et al.,35 Zimmet el al.36 and our own
suggestions was quantiﬁed by kappa statistics (reported with 95%
conﬁdence limits). To assess the degree of agreement, we had to restrict
the database to children with complete data with respect to each of the
four deﬁnitions of metabolic syndrome which led to reduction of the
overall sample size to N= 12 319.
We calculated percentile curves of the continuous MetS as a function of
age stratiﬁed by sex using the GAMLSS method as an extension of the LMS
method. The LMS method models three parameters: the skewness (L)
accounts for the deviation from a normal distribution using a Box–Cox
transformation, the median (M) the outcome variable depending on one
explanatory variable, and the coefﬁcient of variation (S) accounts for the
variation of data points around the mean and adjusts for nonuniform
dispersion. The GAMLSS method is able to model more than one covariate
and to consider other distributions. We used the gamlss package (version
4.2–6) of the statistical software R (version 3.0.1).41 Different distributions,
that is, the Box–Cox-Power-Exponential, Box–Cox t, Box–Cox Cole and
Green and normal distribution were ﬁtted to the observed distribution of
MetS. Moreover, the inﬂuence of age on parameters of the considered
distributions were modelled either as a constant, as a linear function or as
a cubic spline of the covariates.
Goodness of ﬁt was assessed by the Bayesian Information Criterion and
Q–Q plots to select the ﬁnal model including the ﬁtted distribution of MetS
and the inﬂuence of the covariates on distribution parameters. Finally,
curves for the 1st, 3rd, 5th, 10th, 25th, 50th, 75th, 90th, 97th and 99th
percentiles were calculated based on the model that showed the best
goodness of ﬁt.41,42 The best model for MetS in boys and girls consists of a
Box–Cox Cole and Green distribution with parameters modelled as follows:
μ and log(σ) linearly and ν as a constant. Due to missing values for the
HOMA index, we had to restrict our analyses on the continuous total MetS
score to N= 7668 children.
RESULTS
Table 2 shows the prevalence of the metabolic syndrome (MetS)
according to the various deﬁnitions given in Table 1 stratiﬁed by
sex and by weight category. The new deﬁnition which we suggest
as corresponding to a need for close observation of an affected
child (monitoring level) leads to the highest prevalence (5.5%),
whereas the deﬁnition proposed by the IDF Consensus Group36
results in the lowest prevalence (0.4%). The more conservative
deﬁnition we propose for deciding which children may merit
pediatric intervention (action level) gives an overall prevalence of
1.8%, which is slightly higher than the prevalences resulting
from the deﬁnitions by Cook et al.34 (1.4%) and Viner et al.35
(0.9%). Except for the IDF deﬁnition,36 the prevalences tend to be
higher in girls as compared with boys. The most pronounced sex
Table 1. Deﬁnitions of pediatric metabolic syndrome
Deﬁnition Excess
adiposity
Blood pressure Blood lipids Blood glucose/insulin
Cook et al.34 WC ⩾ 90th
percentile37
SBP or DBP ⩾ 90th
percentile28
Triglycerides ⩾ 1.24mmol l− 1 (110mg dl− 1) or HDL cholesterol
⩽ 1.03mmol l− 1 (40mg dl− 1)
Impaired fasting glucose ⩾ 6.11mmol l− 1
(110mg dl− 1)
Viner et al.35 BMI ⩾ 95th
percentile38
SBP ⩾ 95th percentile28 Triglycerides ⩾ 1.69mmol l− 1 (150mg dl− 1) or HDL cholesterol
< 0.91mmol l− 1 (35mg dl− 1) or high total cholesterol ⩾ 95th
percentile39
Hyperinsulinaemia ⩾ 104.2 pmol l− 1 (15 mU l− 1)
or impaired fasting glucose ⩾ 6.11mmol l− 1
(110mg dl− 1)
IDF36 WC ⩾ 90th
percentile37
SBP ⩾ 17.3 kPa
(130mmHg) or DBP
⩾ 11.3 kPa (85mmHg)
Triglycerides ⩾ 1.69mmol l− 1 (150mg dl− 1) or HDL cholesterol
< 1.03mmol l− 1 (40mg dl− 1)
Impaired fasting glucose ⩾ 5.55mmol l− 1
(100mg dl− 1)
IDEFICS14
-monitoring
level
WC ⩾ 90th
percentile16
SBP ⩾ 90th percentile17 or
DBP ⩾ 90th percentile17
Triglycerides ⩾ 90th percentile18 or HDL cholesterol ⩽ 10th
percentile18
HOMA-insulin resistance ⩾ 90th percentile19 or
fasting glucose ⩾ 90th percentile19 a
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; HDL, high-density lipoprotein; IDEFICS, Identiﬁcation and prevention of Dietary- and
lifestyle-induced health Effects in Children and infantS; IDF, International Diabetes Federation; SBP, systolic blood pressure; WC, waist circumference. aAt least
one of both variables had to be available.
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difference is observed for the deﬁnition by Viner et al. where the
prevalence is twice as high in girls (1.2%) as compared with boys
(0.6%). All deﬁnitions classify a small percentage of thin or normal
weight children as being affected by the metabolic syndrome. The
prevalence of MetS increases with weight category and is highest
among obese children according to all deﬁnitions.
The contribution of the various components used for the
deﬁnition of the metabolic syndrome varies substantially between
the different deﬁnitions. This is illustrated in Figure 1 and Table 3.
The cutoffs proposed by Cook et al.34 and Viner et al.35 result in a
near-negligible number of children classiﬁed as hyperglycaemic.
Thus, in both deﬁnitions, glucose and/or insulin levels have only a
minor role as children exceeding the proposed limits only
contribute a very small proportion to the prevalence of MetS.
The same is true for the role of blood pressure in the deﬁnition
proposed by the IDF Consensus Group,36 where the cutoff is
exceeded by only a very small fraction of children.
The proportion of children exceeding the cutoffs empirically
proposed on the basis of the distribution in the IDEFICS cohort
shows more similar proportions for the different components of
the MetS. No component shows extremely low prevalences, giving
about equal chances for each of them to contribute to the overall
prevalence of the MetS in our sample. Although in the deﬁnition
by Cook et al.,34 almost 85% of all children with MetS are classiﬁed
by the same three components, that is, adiposity, hypertension
and dyslipidaemia, in both deﬁnitions we propose, adiposity plus
any combination of the remaining three components are needed
to reach this proportion (Table 3). The component that shows the
greatest independent likelihood of classifying a child as being
affected is dyslipidaemia in all the three existing deﬁnitions,34–36
whereas it is waist circumference in our deﬁnitions.
The degree of agreement between the various deﬁnitions
is limited. Besides the good agreement between both deﬁnitions
we propose, the second best agreement is observed between our
conservative deﬁnition (action level) and the one proposed by
Viner et al.35 (Table 4). According to Landis and Koch,43 this
agreement would be classiﬁed as ‘moderate’ (0.41–0.60) whereas
all other kappa values would be rated as indicating either ‘fair’
(0.21–0.40) or only ‘slight’ (0–0.20) agreement. The lowest
agreement is observed in comparison with the deﬁnition
proposed by the IDF Consensus Group.36 In turn, this shows the
best agreement with the deﬁnition of Cook et al.34 and the
weakest with the monitoring level deﬁnition proposed by us.
Although age-speciﬁc cutoffs were used to deﬁne
metabolic syndrome in children, some deﬁnitions show a higher
prevalence of MetS in older children whereas others do not.
Regarding the IDF deﬁnition, there is only a negligible difference
in prevalence between preschool children up to 5.9 years old
(prevalence = 0.3%) and primary school children (6.0–10.9 years;
prevalence = 0.4%). According to the deﬁnition by Cook et al.,34
the prevalence is 1.4% in both. The deﬁnition of Viner et al.35
results in a prevalence, which is substantially lower in preschool
children (0.3%) as compared with school-aged children (1.3%). A
similar difference is observed with both of our deﬁnitions, which
result in prevalences of 3.4 vs 6.8% and 0.8 vs 2.5%, respectively.
These age similarities and differences run in parallel in both sexes.
The classiﬁcation of an individual child according to any of
these deﬁnitions is complex because it requires the simultaneous
consideration of the age- and sex-speciﬁc cutoff values for all its
components. In our deﬁnition this is further complicated by the
fact, that the blood pressure cutoffs have to consider body height
in addition to age and sex. To facilitate this calculation we offer a
simple web application where the individual measurement values
may be entered to obtain the percentiles and the classiﬁcation of
an individual based on the data of the IDEFICS cohort (www.
ideﬁcsstudy.eu). An approximation of this classiﬁcation is possible
by looking up the age- and sex-speciﬁc percentile values given in
Appendix B and applying the deﬁnitions given in Table 1 for
the IDEFICS monitoring and action levels, respectively. The true
classiﬁcation can only be approximated by using this Appendix as
blood pressure values are not stratiﬁed by body height.
Figure 2 and Table 5 show the age- and sex-speciﬁc percentile
values of the metabolic syndrome score that was derived from the
distribution of blood pressure, blood lipids, waist circumference
and HOMA-IR of the IDEFICS cohort. On average, the score shows a
positive trend with age, particularly in the upper percentiles. The
Table 2. Prevalence of pediatric metabolic syndrome (MetS; three or more characteristics present) according to the deﬁnitions in Table 1 in fasting
normal weight/thin, overweight and obese children
Cook et al.34 Viner et al.35 IDF36 IDEFICS monitoring level IDEFICS action level
No MetS MetS No MetS MetS No MetS MetS No MetS MetS No MetS MetS
N % N % N % N % N % N % N % N % N % N %
Male
Normal/thin 4941 99.6 18 0.4 4958 100.0 1 0.0 4956 99.9 3 0.1 4882 98.4 77 1.6 4948 99.8 11 0.2
Overweight 744 98.3 13 1.7 745 98.4 12 1.6 752 99.3 5 0.7 654 86.4 103 13.6 729 96.3 28 3.7
Obese 415 89.8 47 10.2 440 95.2 22 4.8 443 95.9 19 4.1 325 70.3 137 29.7 408 88.3 54 11.7
Total 6100 98.7 78 1.3 6143 99.4 35 0.6 6151 99.6 27 0.4 5861 94.9 317 5.1 6085 98.5 93 1.5
Female
Normal/thin 4742 99.7 12 0.3 4753 100.0 1 0.0 4753 100.0 1 0.0 4687 98.6 67 1.4 4744 99.8 10 0.2
Overweight 879 97.9 19 2.1 872 97.1 26 2.9 896 99.8 2 0.2 768 85.5 130 14.5 851 94.8 47 5.2
Obese 426 87.1 63 12.9 443 90.6 46 9.4 474 96.9 15 3.1 326 66.7 163 33.3 417 85.3 72 14.7
Total 6047 98.5 94 1.5 6068 98.8 73 1.2 6123 99.7 18 0.3 5781 94.1 360 5.9 6012 97.9 129 2.1
All
Normal/thin 9683 99.7 30 0.3 9711 100.0 2 0.0 9709 100.0 4 0.0 9569 98.5 144 1.5 9692 99.8 21 0.2
Overweight 1623 98.1 32 1.9 1617 97.7 38 2.3 1648 99.6 7 0.4 1422 85.9 233 14.1 1580 95.5 75 4.5
Obese 841 88.4 110 11.6 883 92.8 68 7.2 917 96.4 34 3.6 651 68.5 300 31.5 825 86.8 126 13.2
Total 12 147 98.6 172 1.4 12 211 99.1 108 0.9 12 274 99.6 45 0.4 11 642 94.5 677 5.5 12 097 98.2 222 1.8
Abbreviations: IDEFICS, Identiﬁcation and prevention of Dietary- and lifestyle-induced health Effects in Children and infantS; IDF, International Diabetes
Federation.
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lowest percentiles show no age trend in boys whereas they show
a negative trend in girls. Overall, this ﬁgure corresponds to the
observation of a positive trend of the prevalence of MetS in pre-
adolescent children. But it also reveals a higher variation of the
parameter values contributing to the metabolic syndrome in older
as compared with younger children.
DISCUSSION
Based on the cardiovascular risk factor proﬁle obtained from a
large population-based European cohort of healthy children aged
2.0–10.9 years, we propose a new deﬁnition of pediatric metabolic
syndrome. Previous deﬁnitions show a low degree of agreement
in classifying children as being affected by the metabolic
syndrome. This is due to the fact that they use heterogeneous
and often arbitrary cutoffs for the components when deﬁning
pediatric metabolic syndrome, resulting in different weightings for
the components. Our approach is more consistent in that it uses
sex- and age-speciﬁc cutoffs based on the distribution of all MetS
components in healthy children. This leads to a more balanced
contribution of the single components to the overall prevalence of
MetS in children. In fact, previous deﬁnitions of MetS, when
applied to pre-adolescent children, mostly rely on only three of
the four generally accepted components of this syndrome. In the
deﬁnitions of Cook et al.34 and Viner et al.,35 hyperglycaemia has
only a minor role, whereas the deﬁnition of the IDF fails to take
elevated blood pressure into account. This may suggest limitations
in the existing deﬁnitions, most likely because they are either
based on selected populations like obese subjects or not
speciﬁcally derived for pre-adolescent children. In contrast, the
deﬁnition we propose, while giving particular weighting to waist
circumference, gives roughly equal weight to the other three
components in classifying children as being affected by the
metabolic syndrome.
When we apply the three existing deﬁnitions, the prevalence of
MetS in a large population-based sample of European children
comprising the whole IDEFICS cohort varies between 0.3% (IDF36)
and 1.5% (Cook et al.34) in girls and between 0.4% (IDF36) and 1.3%
(Cook et al.34) in boys. In our deﬁnition, we propose two decision
levels to guide clinical practice where the ﬁrst level may be
considered as a level of concern requiring close observation of
affected children (monitoring level) and the second level may call
for an intervention to ameliorate the risk proﬁle of affected
children (action level). Based on the second level of our deﬁnition,
we observe a prevalence of 2.1% in girls and 1.5% in boys. The
corresponding prevalence based on the monitoring level is 5.9%
in girls and 5.1% in boys. As a consequence, 3.8% girls and 3.6%
boys should be monitored closely with regard to a potential
worsening of their risk proﬁle.
Comparing the prevalences obtained by existing deﬁnitions
with the results from population-based studies in children with a
similar age and using the same deﬁnitions, it seems that the
prevalence in our population lies well in the range of previous
data. In a population-based cohort study44 conducted in 10 and
15 years old youth from Estonia, Denmark and Portugal, the
prevalence of MetS, using the criteria of the IDF Consensus
Group,36 was 0.2 and 1.4% in 10- and 15-year-old children,
respectively, which compares with 0.4% in our sample of children
with the majority of them being younger. In a study of 7–9-year-
old children from Kansas (US),45 the prevalence was 5% according
to the cutoffs by Cook et al.34 which is substantially higher than
the prevalence of 1.4% observed in our cohort when we apply the
same deﬁnition. Further studies reporting prevalences of MetS in
clinical populations and/or adolescents34 are not considered here.
For any of the deﬁnitions of MetS, a clear positive gradient is
seen across weight categories. As expected, by far most of the
children in the obese category are classiﬁed as being affected. But
even in the normal weight/thin category, a small fraction of
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Figure 1. Prevalence of individual components of the metabolic
syndrome (MetS) and of MetS in boys and girls according to ﬁve
different deﬁnitions of MetS (cf. Table 1); BMI, body mass index;
BP, blood pressure; IDEFICS, Identiﬁcation and prevention of
Dietary- and lifestyle-induced health Effects in Children and infantS;
WC, waist circumference.
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children is classiﬁed as being affected. This reﬂects the fact that
the components considered for the deﬁnition of MetS have a
continuous physiological distribution, which does not always
follow the weight status. Just as there are overweight or obese
children who seem to present with a normal metabolic risk proﬁle,
if judged on the basis of the classical MetS components, there are
also normal weight children who are developing an unfavourable
metabolic proﬁle.46 We should also keep in mind that the body
mass index, which is used to deﬁne the weight categories, reﬂects
both fat and fat-free mass, as discussed in Nagy et al.16 (this issue).
This gradient seems to continue even within the obese category
as observed by Sen et al.47 who report a twofold increase of MetS
Table 3. Proportions of different combinations of components of MetS according to the deﬁnitions given in Table 1
Combination Cook et al.34 Viner et al.35 IDF36 IDEFICS monitoring level IDEFICS action level
N % N % N % N % N %
AD+ BP− Lipids+ Glucose+ 4 2.3 29 26.9 26 57.8 198 29.3 88 39.6
AD+ BP+ Lipids− Glucose+ 6 3.5 10 9.3 4 8.9 171 25.3 60 27.0
AD+ BP+ Lipids+ Glucose− 142 82.6 57 52.8 13 28.9 155 22.9 43 19.4
AD+ BP+ Lipids+ Glucose+ 4 2.3 6 5.6 2 4.4 97 14.3 25 11.3
AD− BP+ Lipids+ Glucose+ 16 9.3 6 5.6 0 0.0 56 8.3 6 2.7
All 172 100.0 108 100.0 45 100.0 677 100.0 222 100.0
Abbreviations: AD+/− , adiposity criterion met/not met; BP+/− , blood pressure criterion met/not met; Glucose+/− , hyperglycaemia criterion met/not met;
IDEFICS, Identiﬁcation and prevention of Dietary- and lifestyle-induced health Effects in Children and infantS; IDF, International Diabetes Federation;
Lipids+/− , dyslipidaemia criterion met/not met.
Table 4. Agreement of the various deﬁnitions of the metabolic syndrome (kappa) based on N= 12 319 children with a complete set of
measurements
Viner et al. IDF IDEFICS monitoring level IDEFICS action level
Kappa (95% CI) Kappa (95% CI) Kappa (95% CI) Kappa (95% CI)
Cook et al.34 0.34 (0.26–0.41) 0.25 (0.18–0.33) 0.29 (0.25–0.33) 0.35 (0.28–0.41)
Viner et al.35 0.18 (0.10–0.26) 0.23 (0.19–0.27) 0.46 (0.39–0.53)
IDF36 0.11 (0.08–0.14) 0.19 (0.13–0.25)
IDEFICS monitoring level 0.48 (0.44–0.52)
Abbreviations: CI, conﬁdence interval; IDEFICS, Identiﬁcation and prevention of Dietary- and lifestyle-induced health Effects in Children and infantS;
IDF, International Diabetes Federation.
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Figure 2. Age-speciﬁc percentiles of the IDEFICS metabolic syndrome score for girls (left) and boys (right). IDEFICS, Identiﬁcation and
prevention of Dietary- and lifestyle-induced health Effects in Children and infantS.
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prevalence per one-point increase in body mass index z-score in
352 obese children (2–19 years of age) referred to a children´s
hospital. Thus the gradient of MetS prevalence observed across
the three weight categories is plausible.48
According to most deﬁnitions, the prevalence of MetS is higher
among girls than boys. But this difference seems to be slight.
Observed differences by sex may depend on the cutoffs and
components used in deﬁning MetS—for example, with the IDF
deﬁnition, the prevalence of MetS is slightly higher in boys than in
girls. Using the same deﬁnition, Ekelund et al.44 also report a
higher prevalence of MetS in boys. Sex differences may also vary
by age. Using their own deﬁnition, Cook et al.34 observed a higher
prevalence of MetS in adolescent boys as compared with
adolescent girls.
The prevalence of the risk factors postulated to contribute to
the MetS varies substantially with the cutoffs used (cf. Figure 1).
Likewise, the weight given to the different components of the
MetS differs by deﬁnition. The cutoffs chosen by Cook et al.34 and
Viner et al.35 for glucose/insulin levels are so high that only a very
small number of children exceed the threshold. Consequently, the
prevalence of MetS is mainly driven by the other three
components in these two deﬁnitions. The IDF deﬁnition, however,
uses particularly high cutoffs for blood pressure, which are the
ones deﬁned for adults. Here, blood pressure contributes to a
negligible proportion of children classiﬁed according to IDF as
being affected by the MetS. In fact, all the three existing
deﬁnitions tend to classify children based on only three out of
the four components of MetS. This is not the case for the
classiﬁcation we propose on the basis of the IDEFICS cohort where
each factor—with the exception of adiposity—has about equal
chances to contribute to the overall prevalence of the MetS. It is
therefore not surprising that our deﬁnition results in higher
prevalences than the existing deﬁnitions.
As long as we have no clear evidence that one or more of the
components poses greater risks of cardiometabolic disorders later
in life, it seems reasonable to use a deﬁnition that assigns roughly
equal weights to each of them. Magnussen et al.49 assessed the
contribution of the risk factors included in the deﬁnition of MetS
on the basis of two population-based prospective studies. They
observed a stronger effect of overweight/obesity during child-
hood on carotid intima-media thickness and type 2 diabetes at
24–41 years of age as compared with the other factors. On this
background it makes sense that adiposity receives the highest
weight in the deﬁnition that we propose.
In general, the agreement between the various deﬁnitions
assessed by the kappa coefﬁcient in our cohort may be considered
as slight to moderate. The agreement is mainly limited by two
factors: (1) the great differences of the MetS prevalences and (2)
the different weights given to single components of the MetS.
Disregarding the agreement between the two deﬁnitions we
propose, the highest kappa coefﬁcient is observed for the
deﬁnition by Viner et al.35 and the IDEFICS action level. This may
be due to the more balanced consideration of all four components
by Viner et al.35 compared with the other two previous deﬁnitions.
A low agreement was also observed in a sample of pre-
adolescents girls between the deﬁnition adopted from the
National Cholesterol Education Program Adult Treatment Panel
III and the one adopted from the World Health Organisation.50
The comparisons presented here apply different deﬁnitions to
the same data such that the laboratory assay used does not affect
comparability. This may not be the case when data from other
studies using different assays are to be compared with our results.
It should be noted in this context that all laboratory analyses were
done in a central certiﬁed clinical laboratory participating in
quality control routines according to the standards of good
laboratory practice. The glucose and lipid measurements obtained
by the Colestech point-of-care analyser had previously shown to
be in excellent agreement with the corresponding laboratoryT
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methods (see Peplies et al.;19 this issue). Particularly HOMA and
insulin values may only be applicable to our reference values if
comparable assays were used. Pediatricians using other assays
may want to consider this caveat when referring to our z-scores.
We recognise that the most desirable way to deﬁne MetS would
be in terms of a health-based criterion to deﬁne a cutoff above
which the risk of future disease increases to a relevant and
quantiﬁable degree. In the absence of such information, however,
we believe the best option is to work with a statistical deﬁnition
using plausible percentile values to deﬁne cutoffs. It is for
this reason that we have chosen to propose criteria corresponding
to two different levels of concern. Deﬁning the metabolic
syndrome in children by a single cutoff above which all children
are considered as affected and below which all children are
considered as healthy may be problematic. On one hand our
proposal of two deﬁnitions, one for monitoring and a more
restrictive one for action is a pragmatic way to address a problem
inherent in conditions which lie on continuous distributions. On
the other hand, both in the preventive and clinical settings, there
is no other way to deﬁne a given condition at the individual and
population level than to use cutoffs. Although they are not based
on biological evidence, we believe that the proposed cutoffs are
reasonable and useful for daily practice, because they reﬂect
the most widely used cutoffs to deﬁne the various components of
the MetS.
Rather than simply dichotomising the population into healthy
(no MetS) and unhealthy (MetS) children using an arbitrary cutoff,
the MetS score provides a more ‘physiological’ variable that
accounts for the gradual changes and thus better reﬂects the
continuum between a (putatively) unhealthy and a healthy
metabolic proﬁle. Such a continuous variable is particularly useful
for research purposes and the evaluation of interventions. Used as
an outcome variable in the investigation of detrimental or
preventive effect of an exposure on children’s health, it is much
more powerful than a simple binary variable in detecting possible
associations.20 Our additive MetS score follows the approach by
Eisenmann20 to standardise the distribution of each of the four
parameters included. For children we have no reliable data with
regard to the relative impact of each component on the incidence
of cardiovascular and metabolic diseases later in life. As argued
before, given this lack of knowledge with regard to the predictive
value of each component of the metabolic syndrome, it seems to
be the best decision to assign equal weights to each parameter.
This is assured by our statistical approach. A further strength of
our score is the fact that it accounts for the age- and sex-speciﬁc
distribution of its parameters and that the parameter estimates are
valid for a large, heterogeneous and unselected population of
healthy pre-adolescent children. However, the score also has some
limitations. The parameter values included in the score are
population-speciﬁc. Especially smaller populations may reveal
different distributions and it is therefore desirable to provide data
for the calculation of the MetS score in individuals or other
populations using a large and diverse sample as ours as reference.
To accomplish this, the authors will provide the necessary data as
online material for use in other studies.
As discussed above, the main limitation of our approach is the
lack of a clinically relevant, prospective outcome that would allow
to assess the disease risk in relation to our deﬁnition of the
metabolic syndrome or its single components. However, there are
some results showing an association between metabolic
syndrome and its components during childhood and the risk of
contracting cardiometabolic disorders in adulthood.49,51
Another arguable limitation of our study is our cohort data
involves only one measurement at a single point in time (or two or
three measurements taken x min apart, in the case of blood
pressure) of the physiological markers considered here, when
these markers in fact show substantial day-to-day variations.
This is, of course, important for the individual diagnosis done by a
pediatrician and it is recommended to evaluate a child only on the
basis of repeated measurements. On the population level,
however, such variations should not have an impact on the
overall prevalence estimates.
Like others, we have to rely on a statistical deﬁnition of the
metabolic syndrome. In contrast to many others, it is a strength of
our study that our deﬁnition is based on reference values derived
from a large population-based sample of healthy children from a
heterogeneous European population. The IDEFICS cohort forms
a solid basis for a new-improved deﬁnition of MetS because it is
the largest study of young children to date. This enables us to
calculate robust estimates of the distribution of each risk factor
considered in this deﬁnition. Moreover, we consequently applied
age- and sex-speciﬁc cutoffs that take into account the
physiological development characteristic of the relevant age
group rather than applying ﬁxed cutoffs derived from adult
populations. Our approach leads to a more balanced contribution
of each of the components to the overall makeup of MetS.
The IDEFICS cohort provides the opportunity of assessing the
prevalence of MetS in young, mostly prepubertal children where
the large sample size, the application of highly standardised
measurements and the spread across Europe are particular
strengths. The largest study available before included only
three countries and was restricted to 1604 10-year-old and 1589
15-year-old children.44
CONCLUSIONS
According to the various deﬁnitions of pediatric MetS used in our
analyses, we classify a non-negligible proportion of prepubertal
children as being affected. It has been observed that children with
metabolic syndrome have an increased risk of cardiovascular
diseases in adulthood.51 It is therefore of clinical relevance to
identify those children who are at risk as early in childhood as
possible, as they would probably beneﬁt from lifestyle modiﬁca-
tions. For this purpose, a deﬁnition is needed that guides clinical
practice. However, the existing deﬁnitions of pediatric metabolic
syndrome lead to inconsistent results, leaving clinicians without
clear directions for risk assessment and diagnosis. This situation
may be alleviated by our newly proposed deﬁnition because it
gives more balanced weights to the different components of MetS
and stresses the importance of adiposity as a risk factor for
cardiometabolic disorders later in life. We hope that our newly
proposed deﬁnition will help to improve clinical practice.
The continuous MetS score we developed should not be
considered as competing with the proposed deﬁnition of MetS:
rather than guiding clinical practice the score may serve as a
useful tool in pediatric research and the evaluation of interven-
tions. While clear deﬁnitions and simple cutoffs are needed for
clinical practice, the continuous score corresponds better to the
fact that MetS refers to a complex concept where we are dealing
with predictors of risk that lie on a continuous scale and interact in
complex ways. The metabolic syndrome is not a disease but a
cluster of metabolic disorders. We should therefore be aware of
the fact that every attempt to deﬁne thresholds is an arbitrary
reduction of a complex reality behind it.
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APPENDIX A
Appendix A. Example: age- and sex-standardised z-scores and corresponding additive metabolic syndrome score of four children of the
IDEFICS cohort
Measured values Standardised residuals (z-scores)
Subject Sex Age WC SBP DBP TRG HDL HOMA zWC zSBP zDBP zTRG zHDL zHOMA MetS
score
unit mmHg kPa mmHg kPa mgdl−1 mmol l−1 mg dl−1 mmol l−1
1 M 6.5 59.5 109.0 14.5 67.5 9.0 48 0.54 38 0.98 0.65 1.66 0.85 0.72 0.29 − 1.22 − 0.15 3.05
2 F 5.8 60.4 92.0 12.3 52.5 7.0 50 0.56 52 1.34 1.59 2.20 − 0.96 − 1.77 0.17 0.10 1.39 2.26
3 F 5.2 53.0 94.0 12.5 58.0 7.7 45 0.51 61 1.58 1.00 0.58 − 0.51 − 0.81 − 0.73 0.88 0.68 − 0.07
4 M 5.5 57.5 99.0 13.2 66.0 8.8 78 0.88 45 1.16 0.99 1.64 − 0.13 0.59 1.15 − 0.54 0.71 3.43
Sex: F=girl, M=boy; WC: waist circumference (cm); SBP: systolic blood pressure (mmHg; kPa); DBP: diastolic blood pressure (mmHg; kPa); TRG: triglycerides
(mgdl−1; mmol l−1); HDL: HDL cholesterol (mgdl−1; mmol l−1); HOMA: homeostasis model assessment of insulin resistance; zvar: z-score of the corresponding
variable; MetS score: zWC+(zSBP+zDBP)/2+(zTRG–zHDL)/2+zHOMA.
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APPENDIX B
Appendix B. Age- and sex-speciﬁc cut-offs for the two proposed deﬁnitions of metabolic syndrome with the 90th percentile (P90)
corresponding to the monitoring level and the 95th percentile (P95) corresponding to the action level
B1 Excess adiposity Blood pressure§ Blood lipids Blood glucose/insulin
WC P90 WC P95 SBP P90 SBP P95 DBP P90 DBP P95 TRG P90 TRG P95 HDL P10 HDL P05 HOMA P90 HOMA P95 GLU P90 GLU P95
Boys
3–3.9 52.7 53.8 105.4 108.8 69.0 71.6 84.6 107.0 31.3 26.8 1.03 1.35 92.2 95.9
4–4.9 54.5 55.6 107.5 111.0 69.7 72.4 84.6 107.0 33.3 28.7 1.26 1.62 93.6 97.3
5–5.9 56.2 57.5 109.6 113.1 70.4 73.1 84.6 107.0 35.3 30.6 1.42 1.80 94.9 98.7
6–6.9 58.0 59.5 111.3 115.0 71.0 73.7 84.6 107.0 37.2 32.3 1.55 1.94 96.3 100.0
7–7.9 59.8 61.5 113.1 116.8 71.5 74.3 84.6 107.0 38.5 33.6 1.66 2.06 97.7 101.4
8–8.9 61.7 63.6 114.9 118.6 72.1 74.9 84.6 107.0 39.2 34.3 1.85 2.26 99.1 102.8
9–9.9 63.7 65.8 116.3 120.1 72.6 75.4 84.6 107.0 39.7 34.9 2.14 2.58 100.4 104.1
10–10.9 65.7 68.3 117.8 121.6 73.2 76.0 84.6 107.0 40.4 35.6 2.43 2.90 101.8 105.5
Girls
3–3.9 52.5 53.8 106.0 109.8 70.2 72.8 93.1 115.9 29.3 24.9 1.21 1.55 89.8 93.3
4–4.9 54.3 55.6 107.9 111.6 70.7 73.4 93.1 115.9 31.5 27.0 1.34 1.70 91.1 94.6
5–5.9 55.8 57.3 109.7 113.4 71.3 74.0 93.1 115.9 33.5 28.8 1.47 1.84 92.4 95.9
6–6.9 57.4 58.9 111.2 114.8 71.8 74.4 93.1 115.9 35.5 30.7 1.55 1.91 93.7 97.2
7–7.9 59.2 60.9 112.7 116.3 72.2 74.9 93.1 115.9 37.0 32.1 1.69 2.06 95.0 98.5
8–8.9 61.3 63.2 114.2 117.7 72.7 75.4 93.1 115.9 37.9 33.0 1.96 2.36 96.3 99.8
9–9.9 63.8 65.9 115.7 119.2 73.1 75.9 93.1 115.9 38.2 33.4 2.35 2.79 97.6 101.1
10–10.9 66.6 68.9 117.3 120.7 73.6 76.3 93.1 115.9 38.3 33.6 2.78 3.27 98.9 102.4
B2
Boys
3–3.9 52.7 53.8 14.1 14.5 9.2 9.5 0.96 1.21 0.81 0.69 1.03 1.35 5.1 5.3
4–4.9 54.5 55.6 14.3 14.8 9.3 9.7 0.96 1.21 0.86 0.74 1.26 1.62 5.2 5.4
5–5.9 56.2 57.5 14.6 15.1 9.4 9.7 0.96 1.21 0.91 0.79 1.42 1.80 5.3 5.5
6–6.9 58.0 59.5 14.8 15.3 9.5 9.8 0.96 1.21 0.96 0.84 1.55 1.94 5.3 5.6
7–7.9 59.8 61.5 15.1 15.6 9.5 9.9 0.96 1.21 1.00 0.87 1.66 2.06 5.4 5.6
8–8.9 61.7 63.6 15.3 15.8 9.6 10.0 0.96 1.21 1.01 0.89 1.85 2.26 5.5 5.7
9–9.9 63.7 65.8 15.5 16.0 9.7 10.1 0.96 1.21 1.03 0.90 2.14 2.58 5.6 5.8
10–10.9 65.7 68.3 15.7 16.2 9.8 10.1 0.96 1.21 1.04 0.92 2.43 2.90 5.6 5.9
Girls
3–3.9 52.5 53.8 14.1 14.6 9.4 9.7 1.05 1.31 0.76 0.64 1.21 1.55 5.0 5.2
4–4.9 54.3 55.6 14.4 14.9 9.4 9.8 1.05 1.31 0.81 0.70 1.34 1.70 5.1 5.3
5–5.9 55.8 57.3 14.6 15.1 9.5 9.9 1.05 1.31 0.87 0.74 1.47 1.84 5.1 5.3
6–6.9 57.4 58.9 14.8 15.3 9.6 9.9 1.05 1.31 0.92 0.79 1.55 1.91 5.2 5.4
7–7.9 59.2 60.9 15.0 15.5 9.6 10.0 1.05 1.31 0.96 0.83 1.69 2.06 5.3 5.5
8–8.9 61.3 63.2 15.2 15.7 9.7 10.1 1.05 1.31 0.98 0.85 1.96 2.36 5.0 5.2
9–9.9 63.8 65.9 15.4 15.9 9.7 10.1 1.05 1.31 0.99 0.86 2.35 2.79 5.1 5.3
10–10.9 66.6 68.9 15.6 16.1 9.8 10.2 1.05 1.31 0.99 0.87 2.78 3.27 5.1 5.3
Upper table B1: Blood pressure in mmHg; TRG, HDL, GLU in mgdl1. Lower table B2: Blood pressure in kPa; TRG, HDL, GLU in mmol l1. The tables can only
be used for an approximation because blood pressure cut-offs are not only depending on age but also on height. aBlood pressure percentiles are given
for median height; WC: waist circumference (cm); SBP: systolic blood pressure (mmHg); DBP; diastolic blood pressure (mmHg); TRG: triglycerides (mgdl1);
HDL: HDL cholesterol (mgdl1); HOMA: homeostasis model assessment of insulin resistance; GLU: fasting glucose (mgdl1).
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